Anurag Tarmaster

Anurag Tarmaster

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2024 in Life
Verified
Journal Article
Open access
PDF file
MMMildred Min
Mildred Min
ATAnurag Tarmaster
Anurag Tarmaster
ABApple Bodemer
Apple Bodemer
Raja SivamaniRaja Sivamani
Raja Sivamani
Dietary patterns have been shown to worsen or alleviate several dermatological diseases. A well-balanced, plant-based diet is known to have anti-inflammatory, probiotic, and antioxidant properties, along with weight loss-promoting effects. Moreover, a plant-based diet has a low glycemic load, improving metabolic disease. Due to these qualities, plant-based diets may have beneficial effects on inflammatory skin conditions. In this review, we aim to discuss the possible mechanisms by which a plant-based diet reduces disease severity in psoriasis, acne, hidradenitis suppurativa, and atopic dermatitis. We also aim to clarify how a plant-based diet may influence skin healing and identify sources of vitamins, nutrients, fatty acids, and protein in a well-balanced, plant-based diet. We performed a literature search on PubMed/MEDLINE databases with the following keywords: “plant-based” OR “vegan” OR “vegetarian” OR “meat” OR “diet” AND “psoriasis” OR “hidradenitis suppurativa” OR “acne” OR “atopic dermatitis” OR “skin healing” OR “dermatology”. Our findings demonstrate that plant-based foods may improve inflammatory skin diseases by supporting the gut microbiome, exerting anti-inflammatory effects, providing barrier support, and improving glycemic control. With the proper education, there is an abundance of plant-based food sources or supplements that contain riboflavin, vitamin B12, vitamin A, omega-3 fatty acids, and protein, thereby ameliorating the risk of nutritional deficiencies. Thus, a plant-based diet may have therapeutic potential in dermatology. In spite of the evidence available, there is a paucity of clinical studies focusing specifically on plant-based diets and dermatologic conditions and further investigation is warranted.

26 March 2025
Verified
Journal Article
Closed access
ADAjay S Dulai
Ajay S Dulai
KTKrisha Tripathy
Krisha Tripathy
EMEmi Murase
Emi Murase
ATAnurag Tarmaster
Anurag Tarmaster
ZKZill-E-Huma Khan
Zill-E-Huma Khan
JMJenny E Murase
Jenny E Murase

21 September 2026 in International Journal of Angiology
Verified
Journal Article
Closed access
LCLucy Chu
Lucy Chu
DSDianne Strauss
Dianne Strauss
ATAnurag Tarmaster
Anurag Tarmaster
SASeyed Morsal Mosallami Aghili
Seyed Morsal Mosallami Aghili
MBMohsen Bannazadeh
Mohsen Bannazadeh
Chronic venous insufficiency affects tens of millions of adults in the United States and imposes a substantial economic burden, driven largely by venous leg ulceration. Over the past two decades, endovenous ablation has displaced open ligation and stripping as the primary intervention for symptomatic superficial venous reflux, and the number of available thermal and nonthermal modalities has expanded rapidly. The objective of this study is to describe the currently available endovenous ablation techniques, compare their reported outcomes, and identify gaps in the evidence base that should inform future research. We performed a narrative review of the literature on endovenous ablation of the superficial truncal veins, prioritizing randomized controlled trials, systematic reviews and meta-analyses, and current clinical practice guidelines. Endovenous laser ablation, radiofrequency ablation, and cyanoacrylate adhesive closure achieve comparable short-term occlusion exceeding 90%, with durable 5-year results. Mechanochemical ablation and ultrasound-guided foam sclerotherapy demonstrate lower anatomical durability, and foam sclerotherapy carries the highest recanalization and reintervention rates. Serious thrombotic complications are uncommon across all modalities. Nonthermal techniques avoid tumescent infiltration and thermal nerve injury but have not consistently demonstrated superior periprocedural pain outcomes. Quality-of-life improvement is broadly similar across modalities. Guidelines diverge: the European Society for Vascular Surgery designates thermal ablation as the first-choice treatment, whereas the Society for Vascular Surgery treats thermal and nonthermal ablation as equivalent options. Thermal ablation and cyanoacrylate closure currently offer the most durable outcomes. Long-term comparative data for mechanochemical and steam ablation remain limited, and contemporary cost-effectiveness analyses incorporating nonthermal device costs are needed.

12 May 2026 in International Journal of Angiology
Verified
Journal Article
Closed access
SASeyed Morsal Mosallami Aghili
Seyed Morsal Mosallami Aghili
ATAnurag Tarmaster
Anurag Tarmaster
MBMohsen Bannazadeh
Mohsen Bannazadeh
Thoracic aortic aneurysms (TAAs) are potentially life-threatening and historically managed with open surgical repair. Thoracic endovascular aortic repair (TEVAR) offers a significantly less invasive method to exclude the aneurysm from systemic blood flow, thereby reducing the risks associated with the pre- and postoperative periods. Today, TEVAR is generally accepted as the first choice for most patients with degenerative descending TAAs, and it is being used increasingly for more complex aortic pathologies. Proper patient selection (anatomically suitable) is crucial, particularly for suitable landing zones and vascular access. Improvements in stent-graft design (flexible nitinol-based stents and branched/fenestrated configurations) have made the aortic arch and even the ascending aorta amenable for safe placement of a stent-graft. TEVAR offers improved survival rates, fewer complications, and shorter hospitalizations compared with open surgery. Nonetheless, there remain concerns regarding the long-term durability, particularly in younger patients who may require reinterventions. In addition to the complications typically seen with any form of endovascular repair (endoleaks, device migration, retrograde dissection, spinal cord ischemia), TEVAR also presents unique complications such as stroke. As with any form of endovascular repair, lifelong surveillance using computed tomography scans is required to monitor for late complications, determine the sac behavior of the aneurysm, etc. Regardless of the limitations presented by TEVAR, it has emerged as a major player in the treatment of TAAs. Ongoing refinements in stent-grafts, imaging modalities, and procedural techniques will continue to expand the applications of TEVAR and improve outcomes for an increasing number of patients with thoracic aortic diseases.